PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 69 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,547,739 | +184.5% | 67,293 | +192.7% | 0.00% | +100.0% |
| Q1 2022 | $544,000 | -47.2% | 22,993 | -23.6% | 0.00% | 0.0% |
| Q4 2021 | $1,030,000 | +91.8% | 30,105 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $537,000 | -59.9% | 30,295 | +1.5% | 0.00% | -50.0% |
| Q2 2021 | $1,339,000 | +53.7% | 29,845 | -11.2% | 0.00% | +100.0% |
| Q1 2021 | $871,000 | -1.5% | 33,615 | -23.3% | 0.00% | 0.0% |
| Q4 2020 | $884,000 | -17.8% | 43,825 | -20.3% | 0.00% | -50.0% |
| Q3 2020 | $1,076,000 | -9.4% | 55,015 | -18.3% | 0.00% | 0.0% |
| Q2 2020 | $1,188,000 | +132.5% | 67,305 | -7.0% | 0.00% | +100.0% |
| Q1 2020 | $511,000 | +40.0% | 72,340 | +39.9% | 0.00% | 0.0% |
| Q4 2019 | $365,000 | +350.6% | 51,690 | +327.2% | 0.00% | – |
| Q2 2018 | $81,000 | -30.2% | 12,100 | -10.8% | 0.00% | – |
| Q1 2018 | $116,000 | – | 13,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |